Cargando…

Identification of solamargine as a cisplatin sensitizer through phenotypical screening in cisplatin-resistant NSCLC organoids

Although Cisplatin (DDP) is a widely used first-line chemotherapy medication, DDP resistance is one of the main causes of treatment failure in advanced lung cancer. Therefore, it is urgent to identify DDP sensitizers and investigate the underlying molecular mechanisms. Here we utilized DDP-resistant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Yi, Shi, Jianquan, Xu, Ziwei, Zhang, Yushan, Cao, Xiaoqing, Yu, Jianhua, Li, Jie, Xu, Shaofa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399411/ https://www.ncbi.nlm.nih.gov/pubmed/36034794 http://dx.doi.org/10.3389/fphar.2022.802168

Ejemplares similares

Halofuginone Sensitizes Lung Cancer Organoids to Cisplatin via Suppressing PI3K/AKT and MAPK Signaling Pathways
por: Li, Hefei, et al.
Publicado: (2021)

Solamargine Inhibits the Development of Hypopharyngeal Squamous Cell Carcinoma by Decreasing LncRNA HOXA11-As Expression
por: Meng, Ying, et al.
Publicado: (2022)

Exogenous proline enhances susceptibility of NSCLC to cisplatin via metabolic reprogramming and PLK1-mediated cell cycle arrest
por: Han, Bingjie, et al.
Publicado: (2022)

Identification of Mutations Related to Cisplatin-Resistance and Prognosis of Patients With Lung Adenocarcinoma
por: Li, Rui, et al.
Publicado: (2020)

XPA, XPC, and XPD Modulate Sensitivity in Gastric Cisplatin Resistance Cancer Cells
por: Pajuelo-Lozano, Natalia, et al.
Publicado: (2018)

Inhaled Cisplatin for NSCLC: Facts and Results
por: Kosmidis, Christoforos, et al.
Publicado: (2019)

Solamargine induces autophagy‐mediated apoptosis and enhances bortezomib activity in multiple myeloma
por: Han, Qiaoyan, et al.
Publicado: (2022)

Cisplatin Promotes the Efficacy of Immune Checkpoint Inhibitor Therapy by Inducing Ferroptosis and Activating Neutrophils
por: Zhou, Ziwei, et al.
Publicado: (2022)

Radioresistant Nasopharyngeal Carcinoma Cells Exhibited Decreased Cisplatin Sensitivity by Inducing SLC1A6 Expression
por: Hao, Wenwen, et al.
Publicado: (2021)

Weakening Impact of Excessive Human Serum Albumin (eHSA) on Cisplatin and Etoposide Anticancer Effect in C57BL/6 Mice with Tumor and in Human NSCLC A549 Cells
por: Yang, Zhen, et al.
Publicado: (2016)

Current Strategies to Combat Cisplatin-Induced Ototoxicity
por: Yu, Dehong, et al.
Publicado: (2020)

Sporoderm-Broken Spores of Ganoderma lucidum Sensitizes Ovarian Cancer to Cisplatin by ROS/ERK Signaling and Attenuates Chemotherapy-Related Toxicity
por: Cen, Kaili, et al.
Publicado: (2022)

Dandelion Seed Extract Affects Tumor Progression and Enhances the Sensitivity of Cisplatin in Esophageal Squamous Cell Carcinoma
por: Li, Yuxi, et al.
Publicado: (2022)

Metabolic reprogramming induced by DCA enhances cisplatin sensitivity through increasing mitochondrial oxidative stress in cholangiocarcinoma
por: Qin, Hanjiao, et al.
Publicado: (2023)

Can pharmacogenetics explain efficacy and safety of cisplatin pharmacotherapy?
por: Roco, Ángela, et al.
Publicado: (2014)

Genetic Variations and Cisplatin Nephrotoxicity: A Systematic Review
por: Zazuli, Zulfan, et al.
Publicado: (2018)

Amygdalin as a chemoprotective agent in co-treatment with cisplatin
por: Christodoulou, Panayiota, et al.
Publicado: (2022)

Cisplatin-Induced Anorexia and Pica Behavior in Rats Enhanced by Chronic Stress Pretreatment
por: Guo, Zhijun, et al.
Publicado: (2022)

Daphnetin Attenuated Cisplatin-Induced Acute Nephrotoxicity With Enhancing Antitumor Activity of Cisplatin by Upregulating SIRT1/SIRT6-Nrf2 Pathway
por: Fan, Xiaoye, et al.
Publicado: (2020)

Inhibition of 6-phosphogluconate Dehydrogenase Reverses Cisplatin Resistance in Ovarian and Lung Cancer
por: Zheng, Wujian, et al.
Publicado: (2017)

Inhibition of Glucose-6-Phosphate Dehydrogenase Reverses Cisplatin Resistance in Lung Cancer Cells via the Redox System
por: Hong, Weipeng, et al.
Publicado: (2018)

Characterization of Cardiovascular Alterations Induced by Different Chronic Cisplatin Treatments
por: Herradón, Esperanza, et al.
Publicado: (2017)

The effect of ginger extract on cisplatin-induced acute anorexia in rats
por: Kim, Hyeonah, et al.
Publicado: (2023)

Mangiferin Ameliorates Cisplatin Induced Acute Kidney Injury by Upregulating Nrf-2 via the Activation of PI3K and Exhibits Synergistic Anticancer Activity With Cisplatin
por: Sadhukhan, Pritam, et al.
Publicado: (2018)

Comparison of Myelotoxicity and Nephrotoxicity Between Daily Low-Dose Cisplatin With Concurrent Radiation and Cyclic High-Dose Cisplatin in Non-Small Cell Lung Cancer Patients
por: Zazuli, Zulfan, et al.
Publicado: (2020)

Retinoic Acid Alleviates Cisplatin-Induced Acute Kidney Injury Through Activation of Autophagy
por: Wu, Junxia, et al.
Publicado: (2020)

Matrigel-based organoid culture of malignant mesothelioma reproduces cisplatin sensitivity through CTR1
por: Ito, Fumiya, et al.
Publicado: (2023)

Exosomal Transfer Of Cisplatin-Induced miR-425-3p Confers Cisplatin Resistance In NSCLC Through Activating Autophagy
por: Ma, Yuzhu, et al.
Publicado: (2019)

Overexpression of miR-216b sensitizes NSCLC cells to cisplatin-induced apoptosis by targeting c-Jun
por: Huang, Gang, et al.
Publicado: (2017)

YBX1 mediates autophagy by targeting p110β and decreasing the sensitivity to cisplatin in NSCLC
por: Cui, Yanwei, et al.
Publicado: (2020)

Cisplatin-resistant NSCLC cells induced by hypoxia transmit resistance to sensitive cells through exosomal PKM2
por: Wang, Dongliang, et al.
Publicado: (2021)

Suppression of Cisplatin-Induced Vomiting by Cannabis sativa in Pigeons: Neurochemical Evidences
por: Ullah, Ihsan, et al.
Publicado: (2018)

Sulforaphane Potentiates Anticancer Effects of Doxorubicin and Cisplatin and Mitigates Their Toxic Effects
por: Calcabrini, Cinzia, et al.
Publicado: (2020)

Research Progress on the Functions and Mechanism of circRNA in Cisplatin Resistance in Tumors
por: Mu, Qingchun, et al.
Publicado: (2021)

Phenethylisothiocyanate Potentiates Platinum Therapy by Reversing Cisplatin Resistance in Cervical Cancer
por: Mahapatra, Elizabeth, et al.
Publicado: (2022)

Repositioning of Lansoprazole as a Protective Agent Against Cisplatin-Induced Ototoxicity
por: Wakai, Eri, et al.
Publicado: (2022)

VPA improves ferroptosis in tubular epithelial cells after cisplatin-induced acute kidney injury
por: Li, Yan, et al.
Publicado: (2023)

Proteomic profiling of extracellular vesicles and particles reveals the cellular response to cisplatin in NSCLC
por: Xu, Jiaqi, et al.
Publicado: (2021)

Molecular Mechanisms of Chemoresistance Induced by Cisplatin in NSCLC Cancer Therapy
por: Kryczka, Jolanta, et al.
Publicado: (2021)

Inhibition of DNA-PK by gefitinib causes synergism between gefitinib and cisplatin in NSCLC
por: Pan, Chi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0sbce4frc3uii2atva7kgvnd7d